As of 2026-11-08, the Relative Valuation of Gritstone Oncology Inc (GRTS) is (89.55) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.03 USD, the upside of Gritstone Oncology Inc based on Relative Valuation is -278196.0%.
The range of the Relative Valuation is (82.78) - (84.62) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 31.5x - 44.0x | 37.8x |
| Forward P/E multiples | 28.6x - 32.2x | 30.4x |
| Fair Price | (82.78) - (84.62) | (89.55) |
| Upside | -257180.7% - -262893.6% | -278196.0% |
| Date | P/E |